))
Top Reasons to Embrace Digital Pathology - Andy Ivie
Manage episode 448866882 series 3470506
Treść dostarczona przez Digital Diagnostic Summit & Lumea and Digital Diagnostic Summit. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Digital Diagnostic Summit & Lumea and Digital Diagnostic Summit lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
In this episode of PathPulse: Pathology Innovators in Action, James Thackeray, head of the Digital Diagnostic Summit board, interviews Andy Ivie, a digital pathology software expert. Andy Ivie started his career in digital pathology development in 2013, working as Director of Software Research & Development for Leavitt Medical, Inc. The company was later renamed Lumea, and he now serves as its Chief Technology Officer.
Tune in to listen to his insights on significant changes in the last 12 years with digital pathology, the rationale of going digital (other than AI), artificial intelligence, and recent exciting developments in digital pathology -- all from a behind-the-scenes software perspective.
James and Andy also discuss Andy's featured article in the Digital Diagnostic Digest: Top 5 Reasons to Adopt Digital Pathology Today (Spoiler: AI Isn’t One of Them). Subscribe to the digest to read the full article and more here: https://lumeadigital.com/digital-diagnostic-digest/
Submit questions for our future recordings here: https://lumeadigital.com/ask-a-pathologist-podcast/
Sponsored by the Digital Diagnostic Summit and Lumea.
14 odcinków
Udostępnij
